A comprehensive new report from The Lancet Oncology Commission, presented at the 2026 American Society of Clinical Oncology annual meeting, projects a global shortfall of 99.9 million cancer care workers by 2050. The study warns that without immediate intervention, the gap between rising cancer incidence and available personnel will create an unprecedented crisis, affecting every region from Europe to sub-Saharan Africa.
The largest deficits are expected among nurses—more than 65 million additional nurses will be needed—and diagnostic specialists, including 16 million radiologists and pathologists. Africa and Asia are forecast to be the most severely affected, with shortages of 34.3 million and 57.3 million workers respectively. However, the authors stress that no country will be immune.
Why Europe Is Not Spared
While low- and middle-income countries suffer from brain drain as skilled professionals migrate abroad, high-income nations—including many in the European Union—face their own pressures. Burnout, depression, and budget cuts are straining health systems across the continent. In Germany, for instance, oncology departments report growing difficulty retaining specialist nurses, while France's public hospitals struggle with understaffing in radiology units. The United Kingdom, outside the EU but part of the wider European health landscape, has seen similar trends in its National Health Service.
“Our global initiative brings a clear warning: without urgent action to address critical workforce shortages, we risk a cancer crisis unlike anything we’ve seen before,” said Dr Hedvig Hricak, co-lead of the Commission and a radiologist at Memorial Sloan Kettering Cancer Center in New York. The Commission calls for country-specific strategies, smarter workforce use, task-shifting, and adoption of AI and digital health tools, alongside sustainable financing through public-private partnerships.
Cancer cases are projected to rise from 20 million in 2022 to 35.3 million in 2050, with 18.5 million deaths annually. Approximately 70% of new diagnoses will occur in low- and middle-income countries—the same regions facing the most severe workforce shortages. Lung, breast, colorectal, and prostate cancers are expected to remain the most common globally, while stomach cancer incidence is projected to decline.
Mark Lawler from Queen's University Belfast, a co-author of the study, described the findings as a wake-up call. “Make no mistake; this is a wake-up call, no matter where you are in the world. What we’ve uncovered is shocking — how can we reconcile a 15 million increase in cancer cases diagnosed with a 100 million decrease in cancer staffing? The data unfortunately, does not lie. We can’t wait until 2050 to see if our projections are correct — we must act now.”
The report uses the Global Cancer Workforce microsimulation model, which accounts for demographic, epidemiological, and health system factors across 200 countries and territories. It covers 17 common cancers and 18 workforce types, projecting trends from 2030 to 2050. The authors emphasize that workforce shortages not only delay care for current patients but also hinder future research. “Advances in cancer research globally require a workforce that can generate ideas, design studies, lead teams and translate findings into robust cancer control practices and policies,” they wrote.
For European policymakers, the findings underscore the need to invest in training, retention, and cross-border cooperation. The European Commission's Beating Cancer Plan, launched in 2021, aims to address some of these challenges, but the Lancet report suggests current efforts are insufficient. As the continent grapples with an aging population and rising cancer rates, the shortage of specialists could exacerbate existing disparities between member states.
“Understanding trends in cancer incidence, survival, and workforce — and how they vary by context or geography — is essential for effective cancer control planning and resource allocation,” the authors concluded. The report calls for immediate action, warning that the gap between rising cases and shrinking workforce is not a distant problem but a present reality.
